Biolojic Design Earns Preclinical Milestone from Teva for First AI-Designed Multibody in Autoimmune Disease, TEV ‘325 (formerly BD9) By webadmin@biolojic.com|2026-03-25T16:04:41+00:00March 25, 2026|Press Release|Comments Off on Biolojic Design Earns Preclinical Milestone from Teva for First AI-Designed Multibody in Autoimmune Disease, TEV ‘325 (formerly BD9) Read More
